Skip to content
DataLookout
Menu

NCT06913699

The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 11 words
    • Trial completed
    • Primary completion date changed from estimate of Apr 30, 2026 to Oct 31, 2025
    • Study description expanded, about 10 words
  2. Notable Eligibility criteria shortened, about 9 words
    • Primary endpoints: 1 to 2
    • Study description shortened, about 10 words
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Mertk expression levels of liver tissues
Timeframe: From enrollment to the end of treatment at 4 weeks
C-Kit expression levels of liver tissues
Timeframe: From enrollment to the end of treatment at 4 weeks

Arms and interventions

Procedures: Ultrasonund-guided percutaneous liver biopsy

Sites

1 site in 1 country

  • Shanghai East Hospital (East Hospital Affiliated To Tongji University)Shanghai, Shanghai Municipality, China